首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial
【2h】

Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial

机译:合并症和原发性失眠的序贯心理和药物治疗:一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundChronic insomnia is a prevalent disorder associated with significant psychosocial, health, and economic impacts. Cognitive behavioral therapies (CBTs) and benzodiazepine receptor agonist (BzRA) medications are the most widely supported therapeutic approaches for insomnia management. However, few investigations have directly compared their relative and combined benefits, and even fewer have tested the benefits of sequential treatment for those who do not respond to initial insomnia therapy. Moreover, insomnia treatment studies have been limited by small, highly screened study samples, fixed-dose, and fixed-agent pharmacotherapy strategies that do not represent usual clinical practices. This study will address these limitations.
机译:背景慢性失眠是一种普遍的疾病,与重大的社会心理,健康和经济影响相关。认知行为疗法(CBTs)和苯二氮卓类受体激动剂(BzRA)药物是失眠管理最广泛支持的治疗方法。但是,很少有研究能够直接比较它们的相对和综合益处,很少有研究证明序贯治疗对那些最初对失眠症无反应的人的益处。此外,失眠治疗研究受到小型,高度筛选的研究样本,固定剂量和固定药物治疗策略的限制,这些策略不能代表通常的临床实践。这项研究将解决这些限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号